• Triamcinolone: Practical Research Workflow Guide

  2026-08-26

  Triamcinolone (SKU B1859) provides a research-grade synthetic glucocorticoid agonist for controlled studies of glucocorticoid receptor signaling, inflammation, and immunosuppression. This guide addresses solubilization, assay setup, storage, and quality control; the compound is for scientific research only and is not validated for diagnostic or clinical use.

• Cytarabine (AraC) Workflows for Apoptosis Research

  2026-08-26

  Cytarabine (AraC) provides a controllable DNA-replication stress model for leukemia apoptosis, resistance profiling, and p53 pathway studies. This guide combines practical dosing and readout strategies with a cautious extension into RIPK3-centered viral cell-death research.

• Olive Oil Polyphenols and Cardiovascular Protection

  2026-08-25

  The 2025 reference study compares standard and naturally high-phenolic extra virgin olive oil extracts with hydroxytyrosol and tyrosol across oxidative stress, inflammatory, and cholesterol-efflux assays. Its central contribution is showing that polyphenol concentration and composition influence antioxidant strength, macrophage phenotype, inflammasome signaling, and atheroprotective activity in complementary cellular models.

• Melatonin–Sacchachitin Hydrogel for Atopic Dermatitis

  2026-08-25

  This study developed a melatonin-loaded sacchachitin nanofiber hydrogel as a non-steroidal topical strategy for atopic dermatitis. In a DNCB-induced NC/Nga mouse model, the formulation reduced disease severity, epidermal hyperplasia, mast cell infiltration, and Th2-associated biomarkers while preserving melatonin stability and hydrogel performance.

• Beyond Viability: Measuring Cancer Drug Responses

  2026-08-24

  Hannah R. Schwartz’s dissertation shows that relative viability and fractional viability capture different components of anticancer drug response: growth inhibition and cell killing. Its central practical contribution is a framework for interpreting response magnitude together with response composition and timing, helping researchers design more informative in vitro studies.

• Anlotinib Inhibits Angiogenesis Through Three RTKs

  2026-08-23

  The reference study shows that anlotinib suppresses angiogenesis by simultaneously inhibiting VEGFR2, PDGFRβ, and FGFR1 activation and their shared ERK signaling pathway. Its integrated endothelial-cell, rat aortic ring, and chicken CAM experiments provide a mechanistic framework for studying multi-pathway angiogenesis inhibition in cancer research.

• Calcitriol, NFIA, and Bone Remodeling Assays

  2026-08-22

  Calcitriol and 1,25-dihydroxy vitamin D3 offer a powerful chemical lens for studying bone-cell communication. This article shows how to combine vitamin D receptor signaling with the NFIA bone-homeostasis model to design more interpretable, lineage-resolved assays.

• Oligomycin A as a Mitochondrial Stress Probe

  2026-08-21

  Oligomycin A is a mitochondrial ATP synthase inhibitor that reveals how cells balance oxidative phosphorylation, glycolysis, and ion-homeostasis demands. This article connects mitochondrial stress testing with sodium-driven energy failure and practical assay interpretation.

• Meropenem trihydrate for Resistance Studies

  2026-08-20

  Meropenem trihydrate supports two complementary research modes: direct antibacterial testing and metabolomics-guided analysis of resistant phenotypes. This workflow shows how to connect MIC experiments, controlled compound handling, and LC-MS/MS biomarker discovery without confusing drug response with baseline resistance biology.

• THZ1: Resistance-Aware CDK7 Assay Design

  2026-08-20

  THZ1 is a covalent CDK7 inhibitor with a distinctive C312-directed mechanism. This guide shows how to interpret its transcriptional, antiproliferative, and resistance-related effects using orthogonal assay design.

• O-propargyl-puromycin (OPP) for Protein Synthesis

  2026-08-19

  O-propargyl-puromycin (OPP) converts a brief translation pulse into a click-compatible signal for imaging, flow cytometry, or proteomic enrichment. This workflow shows how to apply OPP to B-cell models of mitochondrial dysfunction while separating global translation changes from cell loss, subset composition, and protein-specific effects.

• Dibutyryl-cAMP, Sodium Salt in Reprogramming

  2026-08-19

  Dibutyryl-cAMP, sodium salt provides a practical way to perturb cAMP-dependent signaling during astrocyte-to-neuron reprogramming workflows. This guide connects DBcAMP sodium salt with the 4F motoneuron study, assay design, quantitative readouts, and troubleshooting without treating the compound as a demonstrated component of the published protocol.

• Metformin Hydrochloride: HO Research Workflows

  2026-08-18

  Metformin Hydrochloride supports more than glucose-metabolism experiments: it enables controlled studies of tendon-derived osteogenesis and heterotopic ossification. This workflow-focused guide covers formulation, concentration screening, Nr4a1/Wnt/β-catenin validation, and troubleshooting for reproducible in vitro and in vivo research.

• o-Agatoxin IVA and Cortical Excitotoxicity

  2026-08-18

  Lustig, Ahern, and Greenberg tested whether blocking P- and Q-type voltage-gated calcium channels with o-Agatoxin IVA could protect cortical neurons from veratridine-, ouabain-, or NMDA-induced injury. The antagonist failed to reduce excitotoxicity at concentrations below 300 nM, showing that inhibition of depolarization-evoked glutamate release does not necessarily produce neuroprotection.

• Diclofenac in Human Intestinal Organoid Assays

  2026-08-17

  Diclofenac is a non-selective COX inhibitor with value beyond conventional inflammation models. This article explains how human iPSC-derived intestinal organoids can separate exposure, metabolism, barrier effects, and prostaglandin biology in more informative assay designs.

455 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page